These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16585176)

  • 1. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
    Hirsch DS; Shen Y; Wu WJ
    Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.
    Duan L; Raja SM; Chen G; Virmani S; Williams SH; Clubb RJ; Mukhopadhyay C; Rainey MA; Ying G; Dimri M; Chen J; Reddi AL; Naramura M; Band V; Band H
    J Biol Chem; 2011 Jan; 286(1):620-33. PubMed ID: 20940296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.
    Schmidt MHH; Husnjak K; Szymkiewicz I; Haglund K; Dikic I
    Oncogene; 2006 May; 25(21):3071-8. PubMed ID: 16407834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
    Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
    Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y; Wu Y; Chakraborty C
    J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Cbl facilitates cytoskeletal effects in v-Abl transformed fibroblast through Rac1- and Rap1-mediated signaling.
    Lee H; Gaughan JP; Tsygankov AY
    Int J Biochem Cell Biol; 2008; 40(9):1930-43. PubMed ID: 18403249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy.
    Hirsch DS; Wu WJ
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):147-57. PubMed ID: 17288526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl.
    Ha Thi HT; Kim HY; Choi SW; Kang JM; Kim SJ; Hong S
    Mol Cell Biol; 2015 Aug; 35(16):2841-50. PubMed ID: 26055326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.
    Chen HY; Yang YM; Stevens BM; Noble M
    EMBO Mol Med; 2013 May; 5(5):723-36. PubMed ID: 23606532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation.
    Wu WJ; Tu S; Cerione RA
    Cell; 2003 Sep; 114(6):715-25. PubMed ID: 14505571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of ERK5 is a novel mechanism by which Cdc42 regulates migration of breast cancer cells.
    Zuo Y; Wu Y; Wehrli B; Chakrabarti S; Chakraborty C
    J Cell Biochem; 2015 Jan; 116(1):124-32. PubMed ID: 25160664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
    Huang Q; Shen HM; Ong CN
    Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc42 induces EGF receptor protein accumulation and promotes EGF receptor nuclear transport and cellular transformation.
    Wang XY; Gan MX; Li Y; Zhan WH; Han TY; Han XJ; Cheng JQ; Wang JB
    FEBS Lett; 2015 Jan; 589(2):255-62. PubMed ID: 25497016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells.
    Prasad NK
    Int J Oncol; 2009 Jan; 34(1):97-105. PubMed ID: 19082482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk.
    Ung CY; Li H; Ma XH; Jia J; Li BW; Low BC; Chen YZ
    FEBS Lett; 2008 Jun; 582(15):2283-90. PubMed ID: 18505685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
    Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
    Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
    Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.